576 / 1241
Identification of a MRI perfusion biomarker to anticipate
progression of glioblastoma after radio-chemotherapy
•
25 patients of spectro glio trial , follow up
> 6 months
•
Analysis of 11 perfusion biomarkers
Khalifa et al, Eur J Radiology 2016
2 months , 4 months and 6 months before the
last MR acquisition with confirmed disease
status were analyzed, with a total of 100 scans
analyzed